Slow processing of dead-cell remains may sustain skin inflammation and dermal growth
In skin–macrophage co-culture, lingering dead-cell remains may prolong inflammation and dermal growth. Persistence after verified complete removal, followed by abolition through selective removal of extrachromosomal material from keratinocytes, would reject this mechanism.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Immune response
Efferocytosis
The engulfment and clearance of apoptotic cells by phagocytes
Where this hypothesis actsSkin after barrier restoration, with dead cellular material still awaiting complete processing
Hypotheses on this target 8
Inhibition5
Activation2
Function preservation
Clearance restoration1
Immunosuppression
Feedback restoration
Rhythm restoration
What is proposed
Clearance restoration
Accelerate complete processing and clearance of residual dead cellular material
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible reduction of recurrent epidermal inflammation and prolonged dermal growth, with stabilization of SPV_6
From the recordИзбирательное подавление ответа кератиноцитов временно снижает воспаление, но устойчивое завершение дермального роста требует завершения переработки.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin repair needs to finish as well as begin if repeated damage is to leave skin functioning normally. The unexpected move is to locate a lasting record of inflammation in dead-cell remains still awaiting disposal, with a few unusually slow portions delaying cleanup despite normal average activity. This is a hypothesis generated by the pipeline, not a measured result.
- An inflammatory episode leaves dead cells and fragments for macrophages to process.
- A few unusually slow portions are proposed to delay later portions, even when average processing activity remains normal.
- Retained remains are proposed to keep inflammation active in the epidermis.
- Prolonged uptake is proposed to sustain signals that reshape the dermis and extend its growth.
- After the protective barrier recovers, another irritation adds material to an unfinished backlog instead of starting after completed cleanup.
- Suppressing keratinocyte responses is predicted to quiet inflammation temporarily while the backlog persists.
- Completing disposal is predicted to let dermal growth end durably.
At a returns counter with one worker, a few parcels that take exceptionally long to handle can leave later parcels waiting even when the average handling time stays the same. Another delivery then joins unfinished work.
Where the picture breaks: Skin has many interacting cells, and the supplied material does not establish that one macrophage must finish processing one portion before handling another. The picture also cannot establish that waiting remains cause inflammation or that their processing prolongs dermal growth.
- Master questionstep 01 of 04
A treatment is sought that would restore the functional condition of middle-aged human skin to that of young people.
Rests on: The supplied goal sets youthful skin function as the target; it does not report that this restoration is achievable.
Stated in the chain - Goal pillarstep 02 of 04
Regeneration, the rebuilding of damaged tissue, must limit itself across repeated rounds of repair.
Rests on: The goal concerns restoring skin function, but does not explain why failure to stop repeated repair is a barrier to that goal.
LeapThe supplied chain does not establish that inadequately limited regeneration contributes to the functional difference between middle-aged and young human skin.
- Gap questionstep 03 of 04
The unresolved issue is whether inflammatory memory, a lasting readiness to respond again after inflammation subsides, remains in the epidermis, the skin’s outer layer, after its protective barrier recovers. The question also asks whether selectively suppressing that memory can stop renewed growth in the dermis, the supporting layer beneath it, without increasing wound reopening or weakening control of potentially cancerous cells.S5
Rests on: Persistent inflammatory memory provides a possible route from one repair episode to the next. A 2024 review in The Journal of Allergy and Clinical Immunology describes such memory after visible psoriasis, an inflammatory skin disease, resolves; it does not establish barrier recovery, repeated dermal growth, or the safety of suppressing that memory.
Supported by literature - Hypothesisstep 04 of 04
Dead-cell remains are proposed to preserve the history of inflammation because a few portions take unusually long to process. Macrophages, immune cells that engulf and process dead material, would sustain inflammation and signals that reshape the dermis while this unfinished material persists. Suppressing keratinocytes, the main cells of the epidermis, is predicted to quiet inflammation temporarily; lasting completion of dermal growth would require finishing disposal.
Rests on: The preceding question supplies the need for an explanation that survives barrier recovery. The hypothesis supplies a conditional basis from queueing theory, the mathematics of waiting work: unusually variable processing times can increase waiting when one processing unit handles portions sequentially. Whether macrophages actually meet that condition is explicitly left for testing.
Stated in the chain
What is carried, and what is not. The screened sources support nearby biological relationships: S3, in Nature in 2022, states that damage-associated molecular patterns, molecules that signal tissue damage, can trigger inflammation, but does not establish prolonged skin inflammation from a disposal backlog; S9, in Science Advances in 2024, reports worse liver inflammation and excess scar tissue in mice with impaired dead-cell clearance, but does not test skin or processing-time variability. These findings bear on the proposed connections between retained material, inflammation and tissue change; none establishes the seven-link sequence end to end.S3S9
Where the reasoning is carried by something unstated · 1
- Goal pillar. The supplied chain does not establish that inadequately limited regeneration contributes to the functional difference between middle-aged and young human skin. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Long-lasting material could be mistaken for a queue that blocks later work. A macrophage might continue accepting new material while slowly breaking down material already inside it, so slow breakdown alone would not establish the proposed bottleneck. What closes it: The proposed shared culture of skin and macrophages must separately record waiting before uptake and time to complete breakdown, and first verify that a slow portion delays subsequent portions. Comparisons must hold dead-cell quantity, average arrival rate and average processing time constant while varying the spread of processing times. Predictions for sudden injury episodes must use measured arrival and processing histories rather than assume steady arrivals.
- Reduced dermal growth after a cleanup intervention could reflect a direct effect on fibroblasts, cells that build and reshape the skin’s supporting material, or on immune cells. Conversely, a response persisting after partial removal could be mistaken for evidence against the hypothesis. What closes it: Controls must separate direct effects on fibroblasts and immune cells from effects of removing remains, as the supplied testing outline requires. Complete removal must be verified before interpreting persistence. The distinguishing comparison also requires checking that removal has not changed deoxyribonucleic acid, or DNA, the cells’ genetic material, or chromatin accessibility, how available packaged DNA is to cellular machinery.
- Fewer dead-cell remains could be mistaken for stronger elimination of abnormal cells, although fewer cells might have been killed. A quieter inflammatory response could likewise be mistaken for safe repair without evidence about wound reopening. What closes it: Death of abnormal cells must be measured separately from subsequent disposal, as the proposal specifies. Wound reopening must also be assessed to answer the gap question; the supplied testing outline does not specify that assessment.
What would make this wrong. The proposal supplies a direct losing result: the repeated response persists after verified complete removal of dead-cell material, but disappears after selective removal of extrachromosomal DNA, genetic material outside chromosomes, from keratinocytes. That would favor the supplied rival, which locates the retained history in copied genetic material. Separately, finding that slowly processed portions do not delay subsequent portions would break the specific queueing mechanism even if dead-cell remains still influenced inflammation.
What it would change. If the hypothesis held, repeated skin repair would depend partly on finishing disposal of earlier damage, and work toward restoring youthful skin function would need to assess the slowest cleanup episodes alongside average activity. Suppressing the outer layer’s inflammatory response alone would not necessarily end the process beneath it. Success in the proposed shared culture would still not establish restored function in middle-aged humans, durable safety against wound reopening or cancer, or improvement in SPV_6, an outcome identifier whose meaning is not supplied.
Sources read · 10
CGRP sensory neurons promote tissue healing via neutrophils and macrophages. · Nature · 2024
“Efferocytosis of neutrophils by macrophages was also greatly enhanced following macrophage treatment with TSP-1 (Fig. ), in line with a previous study suggesting that TSP-1 acts as a bridge between neutrophils and macrophages to facilitate efferocytosis .”
Does not settle: Источник не проверяет очередь остатков погибших клеток, длительность их переработки, связь медленной переработки с сохранением воспаления эпидермиса или ростом дермы, повторное раздражение после восстановления барьера и SPV_6.
Skin Wound Healing: Normal Macrophage Function and Macrophage Dysfunction in Diabetic Wounds. · Molecules (Basel, Switzerland) · 2021
“They also have a reduced ability to phagocytose pathogens and efferocytose cells that have undergone apoptosis. This leads to a reduced capacity to remove pathogens and, as efferocytosis is a trigger for their phenotypic switch, it reduces the number of M2 reparative macrophages in the wound.”
Does not settle: The source does not establish a queue of dead-cell remnants, rare long-processing portions, persistent epidermal inflammation from retained remnants, sustained dermal growth, effects after barrier recovery or renewed irritation, selective keratinocyte-response suppression, completion of processing as a requirement for dermal growth resolution, or stabilization of SPV_6.
Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. · Nature · 2022
“DAMPs trigger inflammatory responses, and may also serve as chemoattractants for macrophages.”
Does not settle: Открытыми остаются связь с кожей, длительность переработки остатков, дермальный рост, восстановление барьера и влияние на SPV_6.
Apoptosis recognition receptors regulate skin tissue repair in mice. · eLife · 2023
“In addition, inhibition of two efferocytosis receptors, Axl and Timd4, abrogates proper wound repair.”
Does not settle: Открытыми остаются длительность и распределение переработки остатков, существование очереди с редкими очень медленными порциями, влияние на воспаление эпидермиса и рост дермы, роль ответа кератиноцитов, а также применимость результатов раннего заживления ран у мышей к устойчивому состоянию кожи.
Inflammatory memory in psoriasis: From remission to recurrence. · The Journal of allergy and clinical immunology · 2024
“A growing evidence base indicates that ‘‘inflammatory memory’’ is retained in tissue after symptoms and signs resolve, which may ultimately herald clinical recurrence at the same site after treatment withdrawal.”
Does not settle: Остаются открытыми роль очереди погибших клеток и их фрагментов, время их переработки макрофагами, связь с воспалением эпидермиса и ростом дермы, а также влияние подавления ответа кератиноцитов на SPV_6.
Keratinocytes: new perspectives in inflammatory skin diseases. · Trends in molecular medicine · 2025
“Beyond these well-established functions, emerging evidence reveals their dynamic interactions with the nervous system and their capacity to retain inflammatory memory.”
Does not settle: Источник не устанавливает роль очереди погибших клеток или их фрагментов, скорость их переработки макрофагами, влияние на дермальный рост, эффект подавления ответа кератиноцитов или стабилизацию SPV_6.
Psoriasis Relapse: Exploring the Role of Epigenetics, Metabolic Reprogramming, and Inflammatory Memory. · Immunological investigations · 2025
“Skin-resident memory T cells and keratinocytes with a history of inflammation play crucial roles in the metabolic and epigenetic alterations observed during relapse.”
Does not settle: Источник не устанавливает роль очереди погибших клеток или их фрагментов, скорость их переработки макрофагами, влияние на дермальный рост, последствия восстановления барьера или показатель SPV_6.
AIM2 and Psoriasis. · Frontiers in immunology · 2023
“Skin epithelial stem cells, which contribute significantly to skin wound healing, were first discovered to have the function of inflammatory memory as nonimmune cells. This trained immunity is mediated by the AIM2 inflammasome.”
Does not settle: Источник не устанавливает, что воспалительную историю поддерживает очередь погибших клеток или их фрагментов, не исследует скорость их переработки макрофагами, длительные задержки, дермальный рост, восстановление барьера или SPV_6.
“We found that Piezo1 was highly expressed in both human and murine fibrotic liver, and mice lacking piezo1 in macrophages exhibited more severe liver inflammation and fibrosis due to the impaired clearance of apoptotic cells.”
Does not settle: Источник описывает фиброз печени, а не кожу. Он не устанавливает существование очереди остатков с редкими длительными задержками переработки, воспаление эпидермиса, рост дермы, влияние восстановления барьера, ответ кератиноцитов или стабилизацию SPV_6.
Macrophage phenotypes and functions: resolving inflammation and restoring homeostasis. · Trends in immunology · 2023
“Here, we present examples from a growing body of recent work highlighting the function of macrophages in restoring homeostasis by clearing dead cells and promoting tissue repair.”
Does not settle: Источник не устанавливает связь между замедленной переработкой остатков погибших клеток и воспалением кожи или ростом дермы. Он не проверяет очередь остатков, длительность их переработки, повторное раздражение после восстановления барьера или показатель SPV_6.
The gap this hypothesis explains
Does skin’s inflammatory memory survive barrier recovery, and can suppressing it safely stop repeated deeper-skin growth?
Original wording · exactly as the pipeline generated it
Сохраняется ли воспалительная память эпидермиса после нормализации барьера, и устраняет ли её избирательное подавление повторный дермальный рост без увеличения раскрытия ран и ослабления противоопухолевого контроля?
What this question is asking
The question concerns whether the skin’s outer layer retains a lasting change caused by inflammation after its protective barrier has recovered. It asks whether selectively suppressing that inflammatory memory stops repeated growth in the dermis, the deeper skin layer, without increasing wound reopening or weakening the body’s control of tumors. The relevant comparison is between skin with recovered barrier function whose inflammatory memory is suppressed and otherwise comparable skin without that suppression. The question treats a connection between lasting memory and repeated growth as a possibility to examine; the supplied sources do not establish that connection. The intended setting is middle-aged human skin, but the input does not define what counts as repeated dermal growth or full barrier recovery.
- Epidermis
- The outer layer of skin. The question locates the proposed inflammatory memory in this layer.
- Skin barrier and barrier normalization
- The skin’s protective function at its surface. Normalization means recovery to a defined reference level, but the input supplies no measurement or threshold for deciding when that has occurred.
- Inflammation
- A tissue response involving immune activity after injury or disturbance. The question distinguishes the earlier response from a lasting change that might remain after visible or functional recovery.
- Inflammatory memory
- A lasting change following earlier inflammation that can affect a later tissue response. Here it is a proposed property of the epidermis, not a demonstrated finding or a single defined substance in the supplied evidence.
- Selective suppression
- An intervention directed specifically at the proposed memory. A treatment that broadly changes inflammation or gene activity does not, by that description alone, establish such selectivity.
- Dermis and repeated dermal growth
- The dermis is the skin layer beneath the epidermis. Repeated dermal growth means recurring growth in that layer, but the input does not identify which cells or structures grow or whether the phrase refers to scarring or another process.
- Wound closure, wound reopening, and wound integrity
- Closure describes a wound becoming covered or closed; reopening describes a previously closed wound opening again. Wound integrity concerns whether the repaired tissue remains intact, so initial closure alone does not answer the reopening question.
- Antitumor control
- The body’s ability to restrain tumor development or growth. The question requires that this protection not weaken, but the input specifies no measurement of it.
- Gene activity and its regulation
- Gene activity concerns how cells use information in their genetic material. Regulation changes how that information is used; several supplied sources address this broad category without establishing that they selectively alter inflammatory memory.
- Histones and histone demethylases
- Histones are proteins around which genetic material is packaged. Histone demethylases are a class of enzymes that remove particular chemical marks from these proteins; S7 reports impaired healing after inhibiting relevant enzymes.
- Butyrate
- The compound used in S1 to alter macrophage function through effects involving histones. The supplied finding concerns wound healing in diabetic mice.
- Macrophages
- Immune cells involved in inflammation and tissue repair. S1 and S2 concern interventions affecting these cells, which does not itself establish memory in the epidermis.
- Inflammation-responsive hydrogel
- A water-containing gel designed to respond to inflammatory conditions. S2 uses it for local delivery of an intervention affecting immune activity.
- Keratinocytes
- Cells forming the main cellular covering of the epidermis. Their activation is mentioned in S2, and restoration of the surface covering is the wound outcome described in S5.
- Atopic dermatitis
- An inflammatory skin disease. S3 reports improved barrier function in models of this disease, which are not identified as models of recovered middle-aged human skin.
- Corin
- The synthetic compound studied in S5, where it inhibits machinery regulating gene activity. The supplied result concerns faster restoration of the surface covering of mouse tail wounds.
- Hair follicle
- The skin structure from which a hair grows. S7 reports effects on its development and growth alongside delayed wound healing.
- Experimental model
- A biological setting used to study a condition or process, such as a mouse wound or a model of skin disease. Its findings establish results in that setting, with applicability to middle-aged human skin remaining a separate question.
- Memory does not persist after recovery Under this outcome, recovered skin would no longer contain the lasting inflammatory change targeted by the question. Suppression of persistent memory would therefore not explain prevention of subsequent deeper-skin growth.
- Memory persists, and suppression safely stops growth Under the proposed mechanism, a lasting change in the outer skin layer would continue to influence growth in the deeper layer after barrier recovery. Stopping that influence would prevent repeated growth while preserving wound integrity and tumor control within the conditions actually assessed.
- Memory persists, but suppression does not stop growth Persistence would establish that barrier recovery and loss of inflammatory memory occur separately. Failure of selective suppression to stop growth would mean that removing this memory is insufficient to produce the proposed benefit.
- Suppression stops growth but compromises safety Repeated deeper-skin growth would stop, but wounds would reopen more often or tumor control would weaken. That outcome would fail the question’s combined requirement of preventing growth while preserving both protective functions.
Barrier recovery, lasting changes after inflammation, and growth in deeper skin are different outcomes; evidence about one does not automatically establish the others. If inflammatory memory remains and drives repeated growth, suppressing it could interrupt the proposed sequence from earlier inflammation to later tissue growth. Whether that also preserves wound integrity and tumor control is a separate part of the question. Mistaking faster wound closure for evidence on all these outcomes would leave the proposed benefit and its safety unestablished.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Проверяемая гипотеза: историю воспаления сохраняет очередь погибших клеток и их фрагментов, которые ещё предстоит полностью переработать. Редкие порции материала с очень длительным временем переработки задерживают завершение всей очереди даже при нормальной средней активности макрофагов. Ожидающие удаления остатки продолжают вызывать воспаление эпидермиса, а растянутое во времени поглощение поддерживает выделение факторов ремоделирования дермы. После восстановления барьера новое раздражение добавляет материал к незавершённой очереди. Избирательное подавление ответа кератиноцитов временно снижает воспаление, но устойчивое завершение дермального роста требует завершения переработки. Сокращение этой задержки должно стабилизировать SPV_6.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Теория очередей и транспортная логистика, модель M/G/1 и формула Поллачека-Хинчина: E[Wq] = λE[S²] / (2(1 − ρ)), где ρ = λE[S] < 1. Логистический аналог представляет собой пункт последовательной переработки возвратного груза. Биологический пункт обслуживания соответствует одному макрофагу с экспериментально подтверждённой последовательной переработкой; заявка соответствует стандартизованной порции погибшего клеточного материала; λ обозначает среднее число поступающих порций в час; S обозначает время занятости переработкой одной порции; E[S] и E[S²] обозначают первый и второй моменты этого времени; ρ обозначает долю занятого времени; Wq обозначает ожидание до начала переработки; E обозначает математическое ожидание. При одинаковых λ и E[S] увеличение E[S²] удлиняет ожидание. Формула требует независимого пуассоновского поступления, стационарности и одного последовательного обслуживающего процесса. Для импульсных повреждений нужны расчёты переходной очереди по измеренным временам поступления и переработки. [Модель M/G/1 в учебнике MIT](https://web.mit.edu/urban_or_book/www/book/chapter4/4.7.html).
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых количестве погибших клеток, средней скорости их поступления и среднем времени переработки более широкий разброс времени переработки увеличивает задержку удаления остатков и продлевает дермальный рост. Удаление оставшегося груза после восстановления барьера сокращает повторный ответ без изменения эпидермальной ДНК или доступности хроматина. Перенос сопоставимого остаточного груза в модель без предшествующего раздражения воспроизводит затяжной ответ, который прекращается после его переработки. Если повторный ответ сохраняется после подтверждённого полного удаления груза, а избирательное удаление внехромосомного материала кератиноцитов устраняет его, эта гипотеза проигрывает IH_Q_L3_M_G4_2_01.
Would tell it apart from at least one rival. The text specifies directional comparisons under matched conditions, an intervention outcome, and an explicit rejection condition. No rival prediction was supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
В совместной культуре кожи и макрофагов можно метить необратимо погибшие клетки и раздельно регистрировать время ожидания поглощения и полного расщепления груза. Сначала необходимо проверить, действительно ли длительная переработка одной порции задерживает следующие. Затем измеренные распределения используются для предсказания ответа независимых образцов. Воздействия на переработку требуют контроля прямого влияния на фибробласты и иммунные клетки. Уничтожение изменённых клеток оценивается по факту их гибели отдельно от последующего удаления остатков.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых количестве погибших клеток, средней скорости их поступления и среднем времени переработки более широкий разброс времени переработки увеличивает задержку удаления остатков и продлевает дермальный рост. Удаление оставшегося груза после восстановления барьера сокращает повторный ответ без изменения эпидермальной ДНК или доступности хроматина. Перенос сопоставимого остаточного груза в модель без предшествующего раздражения воспроизводит затяжной ответ, который прекращается после его переработки. Если повторный ответ сохраняется после подтверждённого полного удаления груза, а избирательное удаление внехромосомного материала кератиноцитов устраняет его, эта гипотеза проигрывает Copying genetic material outside chromosomes may sustain skin's inflammatory memory.
- What would separate them
Copying genetic material outside chromosomes may sustain skin's inflammatory memory predicts: В моделях кожи с одинаковыми исходными водными потерями и проницаемостью для контрольного вещества ответ на повторное раздражение сохраняется после замены макрофагов и удаления остатков погибших клеток. В кератиноцитах при этом обнаруживаются одни и те же внехромосомные соединения последовательностей после нескольких делений, а включение метки в новые копии подтверждает их воспроизведение. После избирательного удаления этих молекул сокращаются продолжительность секреции воспалительных медиаторов и период пролиферации фибробластов. Повторное введение очищенного материала в физиологическом количестве восстанавливает эффект после периода покоя. Если молекулы только разбавляются при делении, их удаление не меняет повторный ответ либо эффект исчезает исключительно после устранения клеточных остатков, гипотеза отвергается. Сохранение прочности и противоопухолевого контроля проверяется отдельно по заранее заданным границам допустимого ухудшения.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.